VijithRoy
☆    

India,
2020-11-20 04:28
(150 d 15:46 ago)

Posting: # 22071
Views: 476
 

 Regarding Steady state study in BE studies [Design Issues]

Hello!

Usually steady state techniques are conducted to maintain constant free drug in plasma with equal elimination. It applies for drugs which come under Time dependent activity.

My question,

1. In what case or particular class of drugs we should go for steady state studies in comparitive BA or BE studies?

2. How does Vidagliptin/metformin (fdc) comes under steady state studies?

Appreciating in advance for your response.

Thank you.


With warm regards,
T. Vijith
Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 9 (0 registered, 9 guests [including 2 identified bots]).
Forum time: Monday 21:14 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5